Edition:
United States

MediciNova Inc (4875.T)

4875.T on Tokyo Stock Exchange

676JPY
9:13pm EDT
Change (% chg)

¥-8 (-1.17%)
Prev Close
¥684
Open
¥679
Day's High
¥679
Day's Low
¥676
Volume
33,600
Avg. Vol
84,383
52-wk High
¥890
52-wk Low
¥510

4875.T

Chart for 4875.T

About

Medicinova, Inc. is a biopharmaceutical company. The Company focuses on acquiring and developing small molecule therapeutics for the treatment of diseases with unmet medical needs and a commercial focus on the United States market. Its pipeline includes MN-166 (ibudilast), MN-001 (tipelukast), MN-221 (bedoradrine) and MN-029... (more)

Overall

Beta: 0.19
Market Cap(Mil.): ¥22,237.04
Shares Outstanding(Mil.): 34.54
Dividend: --
Yield (%): --

Financials

  4875.T Industry Sector
P/E (TTM): -- 138.86 17.42
EPS (TTM): -34.63 -- --
ROI: -26.51 2.17 -5.45
ROE: -29.21 0.04 -4.73

BRIEF-Medicinova announces positive findings from completed trial of MN-166 research

* Medicinova announces positive findings from completed trial of MN-166 (ibudilast) in methamphetamine dependence presented at the 50th winter conference on brain research Source text for Eikon: Further company coverage:

Feb 06 2017

BRIEF-Medicinova announces positive findings on MN-166 (ibudilast) in alcohol dependence

* Medicinova announces publication of positive findings on MN-166 (ibudilast) in alcohol dependence

Jan 23 2017

BRIEF-Medicinova files for offering of up to 869,047 shares by selling stockholders

* Files for offering of up to 869,047 shares of common stock by the selling stockholders

Nov 29 2016

More From Around the Web

Earnings vs. Estimates